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Association of HLA-DR2 genes/gene products has been shown with pulmonary tuberculosis (PTB)
patients in India. In the present study, the influence of HLA-DR2 and non-DR2 genes/gene products
on immunity to tuberculosis has been studied. Plasma samples of -DR2 positive patients (active and
inactive TB) showed a higher antibody titre to Mycobacterium tuberculosis culture filtrate antigens
than non-DR2 (-DR2 negative) patients. Immunoblot analysis revealed a trend towards an increased
percentage of DR2 positive patients recognizing 38, 32/34 and 30/31 kDa antigens of M. tuberculosis
than DR2 negative patients. A low spontaneous lymphoproliferative response (without antigen
stimulation) was seen in HLA-DR2 positive active TB patients than HLA-DR2 negative patients.
However, the antigen stimulated lymphocyte response was higher in the -DR2 positive patients (active
and inactive TB) when compared to non-DR2 patients. Further, an inversional correlation between
antibody titre and spontaneous as well as antigen induced lymphocyte response (measured by 3H
thymidine uptake and expressed as counts per minute) was seen in HLA-DR2 positive active PTB
patients than non-DR2 patients. The present study suggests that HLA-DR2 genes/gene products may
be associated with a regulatory role in the mechanism of disease susceptibility to tuberculosis. The
genes while augmenting the humoral immune response, they suppress the spontaneous and antigen
induced lymphocyte response in -DR2 positive patients with active disease.
Key words Antigen recognition - HLA-DR2-antibody titre - lymphocyte response - Mycobacterium tuberculosis culture
filtrate antigens - pulmonary tuberculosis patients
Human leucocyte antigens (HLA) especially the
class-II antigens have been shown to influence
immune functions. The products of the HLA genes
mediate the recognition and immune response to any
antigen or pathogen by presenting antigens to T
lymphocytes1. The secretion of cytokines such as
tumour necrosis factor- a and interleukin- 1 2 as well
as the lymphocyte response to antigens3,4 are
influenced by HLA genes and their gene products.
Several studies have been carried out to understand
whether the susceptibility and/or immune response
to Mycobacterium tuberculosis is associated with
HLA phenotype and / or controlled by genes linked
to the major histocompatibility complex3,5-12. Studies
in the Asian region, especially in India 6-10 ,
Indonesia5,11 and Russia12 showed a significant
increase  of  HLA-DR2 ant igen f requency in
pulmonary tuberculosis patients. Our recent study on
the role of HLA-class II genes/gene products on
lysosomal enzymes revealed that HLA-DR2
phenotype is associated with a decreased plasma
lysozyme level (an enzyme involved in the non-
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specific killing mechanism of micro organisms) in
active pulmonary tuberculosis (PTB) patients13. It
has been shown in Russians that PTB patients positive
for HLA-DR2 had higher levels of antibodies to M.
tuberculosis than other patients12. Further, humoral
immune response to few epitopes of 38 kDa antigen
of M. tuberculosis is restricted to HLA-DR25,11.
The influence of HLA-DR2 on humoral and cell
mediated immunity in active TB patients, cured
patients and normal healthy subjects has not been
fully established. The present study was aimed at
understanding the role of HLA-DR2 genes/gene
products on antibody and lymphocyte response to M.
tuberculosis culture filtrate antigens in pulmonary
tuberculosis patients and control subjects. The
influence of HLA-DR2 on immunity to tuberculosis
has been studied in both active and inactive stages
(cured) of the disease. Moreover, the influence of M.
tuberculosis antibodies on lymphocyte response in
HLA-DR2 positive and -DR2 negative patients and
controls has also been studied.
Material & Methods
(i) Active tuberculosis patients (ATB) – Patients
attending the Tuberculosis Research Centre (TRC),
Chennai, with respiratory symptoms and radiographic
abnormalities suggestive of pulmonary TB were
studied. These patients had sputum positive for M.
tuberculosis by smear and culture. Blood samples
were taken before the start of chemotherapy. Among
55 ATB patients studied, 48 were males and 7 were
females. The mean age with SE was 38.3±1.7 for
males and 29.3±3.7 for females.
(ii) Inactive tuberculosis patients (ITB; cured
patients) – Patients classified as suffering from active
pulmonary tuberculosis were given anti-tuberculosis
treatment at our Centre. All these patients had
received short course chemotherapy for 6-8 months.
These patients had been treated 10-15 yr earlier. At
the time of blood sample collection all these cured
patients were in the quiescent stage of the disease. Of
the 89 cured patients studied, 66 were males and 23
were females. The mean age with SE was 38.9±1.3
for males and 35.0±1.9 for females.
(iii) Controls – Spouses of cured TB patients living
together for 10-15 yr (family contacts; n=25) and
clinicians, social workers, health visitors, laboratory
volunteers and other staff (n=37) working at TRC for
more than 3 years were studied. Among the 62 control
subjects, 29 were males and 33 were females. The
mean age with SE was 40.1±1.6 for males and
37.6±l.6 for females. All the family contacts and
other control subjects were clinically normal at the
time of blood sample collection.
The patients and spouses were not consanguinous
to each other. The other control subjects were not
related to any of the patients. The patients and the
controls were randomly selected and belonged to the
same ethnic group. They were Tamil speaking south
I n d i a n  p o p u l a t i o n  ( b e l o n g i n g  t o  d i f f e r e n t
communities) living in and around Chennai.
HLA typing : Peripheral blood mononuclear cells
(PBMC) were separated from heparinised blood
samples using ficoll-hypaque density gradient
centrifugation as described by Boyum14. T- and B-
lymphocytes were separated from PBMC using nylon
wool column15 and adherent cell population (enriched
B lymphocytes) was used for HLA-DR typing using
two s tage microlymphocytotoxic i ty  assay1 6 .
Commercial sources of antisera (Biotest, Frankfurt,
Germany) were used for HLA-DR typing and at least
3 antisera were used for each specificity.
M. tuberculosis culture filtrate antigen : H37Rv strain
of M. tuberculosis was grown for 6 wk (late
logarithimic phase) as a surface pellicle on Sauton’s
medium at 37°C. The culture was centrifuged at 3,000
rpm for 30 min to remove the bacilli and the
supernatant was filtered through a Seitz filter (0.45
µm; S e i t z - F i l t e r - W e r k e  G m b H  u n d  C o . ,
Badkreuznack, Germany) to ensure complete removal
of the bacilli. The culture filtrate antigens were
precipitated with 80 per cent ammonium sulphate
and dissolved in sterile phosphate buffered saline
(PBS; pH 7.4). The excess salt was removed by
dialysis using 0.2M, 0.1M and 0.02M PBS (pH 7.4)
at 4°C. The dialysed protein was lyophilised and
resuspended in minimal volume of sterile PBS. The
protein concentration was estimated by Lowry’s
procedure17, against bovine serum albumin (BSA) as
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standard. The culture filtrate protein antigens were
aliquoted and stored at -20°C until required.
Enzyme linked immunosorbent assay (ELISA) : The
IgG antibody titre against M. tuberculosis culture
filtrate antigens was measured by ELISA. The ELISA
plates (polyvinyl chloride; Costar, Cambridge, MA,
USA) were coated with 5 µg/ml concentration of M.
tuberculosis H37Rv culture filtrate antigens. Plasma
samples were serially diluted in PBS (from 1:5 to
1:20480) in the plate using a multichannel pipette.
The plates were incubated at 37°C for 1 h. Rabbit
anti-human IgG peroxidase conjugate (Genei,
Bangalore Genei Pvt. Ltd., Bangalore) was used as
the second antibody in 1: 1000 dilution and incubated
at 37°C for 1 h and washed in PBST (IM PBS pH 7.4
and 0.1% Tween 20). The colour was developed
using orthophenylenediamine (OPD 0.5 mg/ml)
(Sigma Chemical Co., St. Louis , USA) and 0.1 per
cent hydrogen peroxide as substrate. The optical
density was measured at 490 nm in an ELISA reader
(Titertek multiscan plus, MKII, Flow Laboratories
International, Lugano, Switzerland). Twice the mean
optical density (OD) of the blank value was taken as
the cut-off point. Plasma samples showing OD values
above the cut-off were taken as positives and the
corresponding titre values were recorded.
Immunoblotting : M. tuberculosis (H37Rv) culture
filtrate antigen (50 µg/cm gel) was loaded onto a
12.5 per cent sod ium dodecy l  su lpha t e
polyacrylamide slab gel electrophoresis (Protean,
Bio-Rad Laboratories, California, USA) using a
discontinuous tris-buffered system as described
elsewhere18. A molecular weight marker was run
along with the antigen and stained with 0.5 per cent
Coomasie b r i l l i a n t  b l u e  ( R 2 5 0 )  ( B i o - R a d
Laboratories, California, USA). After
electrophoresis, p r o t e i n s  w e r e  t r a n s f e r r e d
electrophoretically to nitrocellulose, paper (NCP)
(Advanced Microdevices Pvt. Ltd., Ambala) by the
method of Towbin et al 19, in a blot apparatus
(Transblot apparatus, Bio-Rad Laboratories,
California, USA) for 1 h at 65 mA constant current.
The NCP strips were treated with the plasma samples
of the patients (1:50 dilution), rabbit anti-human IgG
peroxidase conjugate as second antibody (1: 1000
dilution), (Genei, Bangalore Genei, Bangalore),
hydrogen peroxide as substrate and colour was
developed using diamino-benzidine (0.04%) (Bio-
Rad Laboratories, California, USA) in PBS as the
chromogenic substance. One strip for positive control
(hyper immune rabbit serum against M. tuberculosis
H37Rv strain) was included in each set of experiments.
Anti-rabbit IgG peroxidase was used as second
antibody (1:5000).
Lymphocyte transformation test : Peripheral blood
mononuclear cells (PBMC) of ATB and ITB patients
and controls were suspended in RPMI tissue culture
medium (Sigma Chemical Co., St. Louis, USA)
supplemented with 2mM L-glutamine ((Flow
Laboratories, Irvine, Scotland, UK), gentamycin (10
µg/ml) (M.A. Bio Products, Walkerville, Maryland,
USA), fungizone (5 µg/ml) (Squibb, Princeton, NJ,
USA) and 10 per cent autologous plasma for controls
and cured patients. Autologous serum was used
instead of plasma in the cultures set up with active
tuberculosis patients samples to avoid clotting. No
difference in the counts were observed when
autologous plasma or serum was used. 0.1 x 106
PBMC in 200 µl were cultured with or without 10
µg/ml concentration of M. tuberculosis culture filtrate
antigens for 6 days in a 96 well ‘U’ bottom tissue
culture plate (Costar, Cambridge, MA, USA). at 37°C
and 5 per cent carbon dioxide in a CO, incubator
(Flow Laboratories Ltd., Rickmansworth, Hertz, UK).
Tritiated thymidine [(3H) BARC, Trombay, Mumbai]
was added to each well (1µCi/well) 16 h before
termination. The cells were harvested onto glass fibre
filters using a PHD cell harvester (Cambridge
Technology, Inc, Water Town, MA, USA). The
lymphocyte response to M. tuberculosis antigen was
measured by tritium labelled thymidine uptake by
the cells in a scintillation system and Beta counter
(LKB, Wallac Oy, Turku, Finland) and expressed as
counts per minute (cpm). The mean cpm value of the
triplicate culture was calculated and the stimulation
index (SI) was derived20 using the formula:
SI : mean cpm of antigen stimulated cell cultures
mean cpm of cell cultures without antigen
Statistical analysis : The frequencies of HLA-DR
antigens in patients and controls were determined by
direct allelic count. The results on antibody titre and
lymphocyte response are expressed as mean ± SE.
Student’s ‘t’ test was used to see the significance of
SELVARAJ et al : HLA-DR2 PHENOTYPE ON IMMUNITY TO TUBERCULOSIS 211
the data. Significant P values were further corrected
(PC) by multiplying the P value for the number of
antigens studied for -DR locus. Proportionality test
was used for immunoblot analysis to find out the
significance.
Results
A trend towards an increased antibody titre to M.
tuberculosis culture filtrate antigen was seen in HLA-
DR2 positive active and cured TB (inactive TB)
patients than -DR2 negative patients. However, a
significant increase in the antibody titre was seen
only in cured TB patients (DR2 + ve vs DR2 - ve :
P < 0.001 : Pc < 0.01) and not in the active TB
patients (Fig. 1).
Most of the DR2 positive and DR2 negative ATB
patients recognized 38 kDa antigen. However, an
intense recognition pattern of 38 kDa antigen by the
plasma of DR2 positive ATB patients was seen when
compared to non-DR2 (-DR2 negative) ATB patients.
Further, the plasma samples of the -DR2 positive
cured (ITB) patients showed an increased recognition
of 38 kDa antigens. However, this increase was not
significant (P > 0.05). Moreover, a trend towards an
increased recognition of 32/34 and 30/31 kDa M.
Fig. 1. HLA-DR2 and antibody response to M. tuberculosis culture Fig. 2. M. tuberculosis culture filtrate antigen (molecular weight in
filtrate antigen in control, active-TB and inactive-TB patients. kDa) recognition pattern by plasma samples of HLA-DR2 positive
Results are expressed as mean ± SE. ATB : DR2+ve vs DR2 -ve : and -DR2 negative control subjects and pulmonary tuberculosis
P > 0.05; ITB : DR+ve vs DR2-ve : P < 0.001; Pc < 0.01; Pc- (ATB and ITB) patients. Controls : DR2 +ve, n = 17 and DR2 -ve,
corrected for the number of DR antigens studied (i.e., DR1 to n = 45; Active-TB : DR2 +ve, n = 27 and DR2 -ve, n = 28: and
DR10). Inactive-TB : DR2 +ve, n = 48 and DR2 -ve, n = 41.
tuberculosis antigen complexes were seen in the
-DR2 positive patients (ATB and ITB) and control
subjects than -DR2 negative individuals. However,
these increased trends were not significant (Fig. 2).
A low spontaneous lymphoproliferative response
(without antigen stimulation) was seen in HLA-DR2
positive ATB patients (1,981.1 ± 279.3 cpm) than
-DR2 negative patients (7,785.5 ± 2.979.5 cpm).
However, the difference was not significant (P >
0.05). A similar trend was also seen in -DR2 positive
cured (inactive TB) patients. However, such a trend
was not evident in -DR2 positive control subjects
(Table).
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Table. Influence of HLA-DR2 on spontaneous and M. tuberculosis culture filtrate antigen induced lymphocyte response in control subjects
and patients
HLA
DR2
Counts per minute (cpm)
Spontaneous
response
M. tuberculosis#
Antigen induced
response
Stimulation
index
Control subjects
n=50
Positive 3,523.4±1,252.4 22,309.9±5.085.4 6.3**
n=13 (14.1±3.5)*
Negative 3,299.1±526.5 23,112.4±3,480.1 7.0**
n=37 (12.2±2.2)*
Active-TB
patients
n=44
Positive
n=20
Negative
n=24
1,981.1±279.3 10,486.4±2,525.0 5.3**
(6.7±2.1)*+
7,785.5±2,979.5 14,206.8±4,461.3 1.8**
(2.7±0.4)*$
Inactive TB
patients
n=38
Positive
n=21
1,244.5±254.7 29,754.8±5,217.1 23.9**
(34.5±9.2)*
Negative 2,286.8±923.0 29,610.5±5,462.4 13.0**
n=17 (24.6±5)*
P+ < 0.05 as compared to DR2 +ve ITB patients
$ < 0.001 as compared to DR2 -ve ITB patients
# 10 mg/ml concentration of M. tuberculosis culture filtrate antigen was used in the culture; ** Stimulation indices calculated collectively
for all subjects; * Stimulation indices calculated for each subject separately and expressed as mean ± SE
The M. tuberculosis culture filtrate antigen induced
lymphocyte response (Stimulation Index:SI) was
higher in -DR2 positive ATB (6.7 ± 2.1) and ITB
patients (34.5 ± 9.2) than -DR2 negative ATB
(2.7 ± 0.4) and ITB patients (24.6 ± 5.0). However,
the differences were not significant (P > 0.05). The
-DR2 positive control subjects did not show an
increased response when compared to -DR2 negative
subjects. Further, the antigen induced lymphocyte
response (SI) was lower in the active TB patients
than inactive TB patients (DR2 +ve ATB vs DR2
+ve ITB : P < 0.05; non-DR2 ATB vs non -DR2 ITB
: P < 0.001; Table).
The influence of antibody titre on spontaneous
and antigen induced lymphocyte response and vice
versa were analysed for -DR2 positive and DR2
negative ATB and ITB patients and controls. A
marked inversional correlation with antibody titre on
spontaneous lymphoproliferative response was seen
in HLA-DR2 positive ATB patients. On the other
hand, a direct correlation was seen with HLA-DR2
negative patients with active disease (Fig. 3). A
similar trend on the inversional correlation between
antibody titre and M. tuberculosis culture filtrate
antigen induced lymphocyte response (3H-thymidine
uptake - cpm) was also evident with -DR2 positive
and -DR2 negative ATB patients (Fig. 4a). A similar
picture was also seen with -DR2 positive and -DR2
negative control and cured patients (data not shown).
However, such an inversional correlation was not
observed with antibody titre and stimulation indices
(SIs) of lymphocyte response to M. tuberculosis in
HLA-DR2 positive and -DR2 negative ATB patients
(Fig. 4b). On the other hand, the antibody titre and
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Fig. 3. Influence of antibody titre on spontaneous lymphoproliferative response in HLA-DR2 positive and -DR2 negative control subjects,
active-TB and inactive-TB patients. (i) Control subject (-DR2 negative) and inactive-TB patient (-DR2 positive) showing antibody titres of
2560 are represented as 1500. (ii) Two active-TB patients (-DR2 positive) showing antibody titres of 10,240 are represented as 6000. (iii)
Active-TB patients (3) (-DR2 negative) showing cpm of 32,008, 57,532 and 40,540 are represented as 20,000 cpm.
the stimulation indices of the antigen induced
lymphocyte response were directly correlated with
HLA-DR2 and negatively correlated with non-DR2
patients with active tuberculosis (Fig. 4b).
Discussion
An increased antibody titre to M. tuberculosis
culture filtrate antigen was seen in HLA-DR2 positive
active TB and cured TB patients. Similar increase in
antibody levels against M. tuberculosis antigens has
been shown in HLA-DR2 positive Russian PTB
patients12. This suggests that HLA-DR2 may be
associated with humoral immune response. However,
in the present study, a significant increase in antibody
titre was not seen in DR2+ve active TB patients. This
suggests that the influencing effect of -DR2 on
antibody response may be regulated/masked by other
factors released by monocytes/macrophages,
lymphocytes and / or other cells. Suppressive effect
of monocytic and lymphocytic factors on immune
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Fig. 4a. Influence of antibody titre on M. tuberculosis culture filtrate antigen (10 µg/ml) stimulated lymphocyte response (3H-thymidine
uptake-cpm) in HLA-DR2 positive and -DR2 negative ATB patients. b. Influence of antibody titre on stimulation indices (SIs) of lymphocyte
response to M. tuberculosis culture filtrate antigen (10 µg/ml) in HLA-DR2 positive and -DR2 negative ATB patients. (i) -DR2 positive
ATB patients (n = 2) showing antibody titres of 10,240 are represented as 6000 in Fig. 4a&b. (ii) - DR2 negative ATB patient (n=1) showing
a cpm of 82592 is represented as 60,000 in Fig. 4a. (iii) -DR2 positive ATB patient (n = 1) showing a SI of 36.1 is represented as 30 in Fig.
4b.
response has been shown in PTB patients21,22. Such
an immunoregulatory effect on antibody response is
not seen in cured patients. This suggests that the
inhibitory effect of the suppressive factors may not
be present in the cured patients.
The immunoblot analysis revealed a trend towards
an increased recognition of 38, 32/34, 30/31 kDa
antigens by -DR2 positive patients (ATB and ITB)
than -DR2 negative patients. It has been shown that
M. tuberculosis 38 kDa antigen is HLA-DR2
restricted. Two of 38 kDa antigen epitopes (TB71
and TB72) are -DR2 restricted. Higher antibody to
these epitopes has been shown in Indonesian PTB
patients positive for HLA-DR15, a sub-type of
-DR25,11. In the present study a trend towards an
increase in the 38 kDa recognition by HLA-DR2
positive patients (ATB and ITB) was seen. Moreover,
38 kDa antigen was intensely recognised by HLA-
DR2 positive active TB patients than non-DR2
patients. This suggests that higher antibody levels
may be produced by -DR2 positive patients during
the active stage of the disease. This indicates that the
38 kDa antigen as such may not be HLA-DR2
restricted, probably few epitopes may be HLA-DR2
restricted. The present study also reveals that a few
of the 32/34 30/31 kDa antigenic determinants of M.
tuberculosis may be restricted to HLA-DR2.
However, this needs further study.
The spontaneous lymphoproliferative response
(without antigen stimulation) and antigen induced
lymphocyte response (as measured by 3H thymidine
uptake : cpm) were low in -DR2 positive active TB
patients than - DR2 negative patients. However, the
basal antibody titre to M. tuberculosis antigens was
higher in -DR2 positive ATB patients than -DR2
negative patients. On the other hand, an increased
spontaneous lymphoproliferative and antigen induced
lymphocyte response (cpm) and an increased basal
antibody titre were seen in non-DR2 (-DR2 negative)
patients with active stage of the disease. This suggests
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that the inverse correlation between antibody titre
and spontaneous lymphoproliferative response and
antigen induced lymphocyte response (cpm) may be
associated with HLA-DR2 antigens in active TB
patients.
Higher antibody titre to M. tuberculosis culture
filtrate antigens in tuberculous sera has been shown
to be inversely  corre la ted wi th  blas togenic
responses23. Moreover, it has been shown that
immunoglobulin G (IgG) antibody levels against M.
tuberculosis antigen 85 complex (30, 31 and 31.5
kDa) in pulmonary tuberculosis patients were also
inversely correlated with lymphoproliferation and
IFN- g secretion24 However, our recent studies on.
antibody titre and spontaneous tlastogenic response
and M. tuberculosis culture filtrate antigen induced
lymphoblastogenic response revealed no inversional
correlation (unpublished observations).
Interestingly, a trend towards an inversional
correlation between antibody titre and spontaneous
blastogenic response and antigen induced lymphocyte
response (cpm) were seen in HLA-DR2 positive
active PTB patients than non-DR2 patients. However,
such a down regulating effect of antibody titre was
not seen on stimulation indices of M. tuberculosis
culture filtrate antigen induced lymphocyte response
in HLA-DR2 positive active PTB patients. The
stimulation index of the antigen induced lymphocyte
response is directly proportional to antibody titre in
HLA-DR2 positive ATB patients. Whereas, a
decreased antibody titre and a low stimulation index
in non-DR2 (DR2 negative) patients is also directly
related but showed a negative correlation. Since,
stimulation index is a proportional increase (relative
increase) to the spontaneous response, the picture on
st imulat ion index represented an increased
lymphocyte response to the antigen and is associated
with HLA-DR2 and a decreased response with non-
DR2 (DR2-negative) ATB patients. In HLA-DR2
positive ATB patients, the decreased spontaneous as
well as antigen induced lymphocyte response (cpm)
observed during the active stage of the disease, may
be due to higher level of M. tuberculosis antibody
and/or the components of M. tuberculosis (proteins,
lipids and carbohydrate moieties) which may affect
the antigen presentation by macrophages to T
lymphocytes either by binding with the processed
antigens and/or binding with various receptors of T
cells and blocking and effective antigen recognition.
In Southern Asian Indian patients with PTB, DR2
was more strongly associated with far-advanced,
smear positivity cases than with cases of minimal
and moderate radiographic lung lesions7. Further,
extensive disease occurred significantly more
frequently in patients with drug-failure in whom DR2
was overwhelmingly present10. This suggests that,
during the initial stage of active tuberculosis a better
cell mediated immune response may be mounted
against M. tuberculosis in both HLA-DR2 positive
and -DR2 negative patients. Since HLA-DR2 is
associated with far advanced disease7, the factors that
are released by the M. tuberculosis  infected
monocyte/macrophage may suppress the immune
system and permit the bacilli to grow which may lead
to advanced disease. During the stage of advanced
disease, the bacillary load will be high and may
produce more secretory, excretory protein antigens
which trigger the system to higher antibody
production. At the same time cell wall components
other than proteins which consist of lipids and
carbohydrates etc., may also be released both from
live and dead bacilli into the system which may
affect the antigen presentation by macrophages and
antigen recognition by T-cells.
The other  poss ib i l i ty  for  th is  decreased
spontaneous and antigen induced lymphocyte (cpm)
response may be due to the factors/cytokines that are
released by the infected monocytes/macrophages
which may regulate the cell mediated as well as
humoral immune response. During the initial stage
of active tuberculosis, the bacillary load may be less
and a better cell-mediated immune response may be
seen, when the bacillary load increases during
moderate and advanced disease the CMI response
may be over come by humoral immune response
which may result in anergy to M. tuberculosis
antigens and an increased antibody titre. Based on
the cytokine secretion pattern by the T-cell subsets,
T-helper type 1 (Th 1) (associated with CMI
response), T-helper type 2 (Th2) (associated with
humoral immune response), and mixed T-helper type
0 (Th0) (associated with both humoral and CMI
response), have been established in mycobacterial
diseases25-27. Recently, HLA-DR polymorphism has
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been shown to modulate the cytokine profile to M.
leprae heat shock proteins26. It has been suggested
that the major histocompatibility complex phenotypes
of the antigen presenting cell can modulate Thl-like
versus Th2-like activity against M. leprae pathogens
in leprosy and healthy individuals26. This suggests
that the association of HLA-DR2 on tuberculo-
immunity may be regulated by various cytokines
released by different sub-sets of T-helper cells (Th1,
Th2 and/or Th0) and/or other factors that are released
by the monocytes and/or lymphocytes during the
active stage of the disease.
Moreover, molecular subtyping of HLA-DR2
revealed that HLA DRBI * 1501 and *150210 and
DRBI * 1501 (Pitchappan RM, unpublished) are
associated with pulmonary tuberculosis in north
Indian and south Indian patients respectively. Further
studies on the influence of HLA-DR2 subtypes on
tuberculo-immunity may substantiate the mechanism
of disease susceptibility and the pathogenesis of the
disease. The present study suggests that HLA-DR2
genes/gene products either alone or in combination
with other major histocompatibility complex (MHC)
genes may influence both humoral and cell mediated
immune responses. However, further functional
studies are needed to substantiate our data.
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